in past times number of years, the UK has witnessed a revolution in health-related bodyweight‑loss therapies — from the introduction of semaglutide (Wegovy®) to the increasing recognition of tirzepatide (Mounjaro®). Now, A different name is drawing awareness in both equally medical and community